GCC IVF Market: Focus on Procedure, End User, Product, and 8 Countries’ Data - Analysis and Forecast, 2023-2033
Report Highlights
GCC IVF Market Witnesses Phenomenal Growth, Paving the Way for Advanced Reproductive Healthcare
The healthcare landscape in the GCC region has undergone significant improvements, characterized by the proliferation of specialized fertility clinics providing advanced IVF treatments. This surge is complemented by supportive policies and regulations implemented by GCC governments, acknowledging the importance of reproductive health, and ensuring oversight of the IVF industry.
Technological advancements, such as preimplantation genetic testing (PGT) and in vitro maturation (IVM), have notably enhanced the success rates of fertility treatments in the GCC. The market further benefits from a growing trend in medical tourism, drawing individuals from neighbouring regions seeking accessible and high-quality IVF services within the GCC.
The GCC's IVF market stands at the threshold of ongoing expansion, propelled by shifting demographics, improved healthcare infrastructure, favourable regulatory environments, and continuous advancements in reproductive medicine. This sector is anticipated to play a pivotal role in addressing challenges related to infertility in the region.
Market Segmentation:
Segmentation 1: by Product
- Systems
- Media Reagent
- Accessories and Consumables
Segmentation 2: by Type
- Conventional IVF
- IVF with Intracytoplasmic Sperm Injection (ICSI)
Segmentation 3: by Procedure
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
Segmentation 4: by End-User
- Commercial Labs
- Fertility Clinics
- Hospital Systems
- Other End-User
Segmentation 5: by Country
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
- Kuwait
- Bahrain
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2023 |
| Forecast period considered | 2023-2033 |
| Segments covered | By Product, By Type, By Procedure, By End-user, By Country |
| Industry covered | BIS Healthcare |
| Regions covered | GCC |
| Countries covered | United Arab Emirates, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain |
| Companies studied |
|
Key Questions Answered:
- What was the market size of the GCC in-vitro fertilization market in 2022?
- Which technique segment holds the highest dominance in the GCC in-vitro fertilization market?
- Which segment exhibits the most dominance in the GCC in-vitro fertilization market?
- What are the primary factors propelling the GCC in-vitro fertilization market?
- What opportunities, risks, and overall market landscape characterize the in-vitro fertilization market?
- What significant market trends are influencing the expansion of the in-vitro fertilization market?
This report will be delivered in 3-5 working days.
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
Similar Reports from BIS Research
Global In-Vitro Fertilization Market: Focus on Products, Types, Procedures, and End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030
Global In-Vitro Fertilization Market to Reach $51.51 Billion by 2030
Market Report Coverage - In-Vitro Fertilization
Market Segmentation
- Product – Systems, Media and Reagents, Accessories and Consumables
- Type – Conventional IVF, IVF with Intracytoplasmic Sperm Injection (ICSI)
- Procedure – Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor
- End User - Commercial Labs, Fertility Clinics, Hospital Systems, Other End Users ...